Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Paroxetine relieves pain by increasing allopregnanolone levels.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Antiandrogens block male hormones and are not safe during pregnancy.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.